Financiere des Professionnels - Fonds d,investissement »

Catalyst Pharmaceutical Partners shares owned by Financiere des Professionnels - Fonds d,investissement

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Financiere des Professionnels - Fonds d,investissement from 13F filings

Historical chart of Financiere des Professionnels - Fonds d,investissement investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Financiere des Professionnels - Fonds d,investissement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Financiere des Professionnels - Fonds d,investissement

Quarter filed Position value Share count Share price at filing
2025-06-30 $206k 9.5k 21.70

More positions owned by Financiere des Professionnels - Fonds d,investissement

Ishares Core Msci Emkt (IEMG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
Charles Schwab Corporation (SCHW)
Becton, Dickinson and (BDX)
Ishares Tr Msci Emg Mkt Etf (EEM)

View all positions for Financiere des Professionnels - Fonds d,investissement

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management
Northern Trust

View all funds holding Catalyst Pharmaceutical Partners